Charles River Laboratories International Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2012 | $527.1M | $600.8M | $109.7M |
| FY2013 | $641.8M | $641.0M | $155.9M |
| FY2014 | $722.0M | $672.2M | $160.0M |
| FY2015 | $821.0M | $733.1M | $117.9M |
| FY2016 | $1.19B | $836.8M | $117.6M |
| FY2017 | $1.09B | $1.05B | $163.8M |
| FY2018 | $1.63B | $1.32B | $195.4M |
| FY2019 | — | $1.63B | $238.0M |
| FY2020 | — | $2.11B | $228.4M |
| FY2021 | — | $2.53B | $241.2M |